Treatment conditions
| Strain | Control | EtOH exposed | ||
|---|---|---|---|---|
| BEC | N | [Vapor] | ||
| n | mg/ml | n | mg/liter | |
| B6 | 15 | 1.51 ± 0.09 | 52 (78) | 6.0, 7.5, 9.0 |
| D2 | 24 | 1.50 ± 0.06 | 28 (58) | 3.0, 4.5, 6.0, 7.5 |
| BXD 1 | 8 | 1.51 ± 0.18 | 15 (19) | 6.0, 7.5, 9.0 |
| BXD 2 | 9 | 1.53 ± 0.11 | 26 (37) | 6.0, 7.5, 9.0 |
| BXD 5 | 3 | 1.48 ± 0.21 | 12 (21) | 6.0, 7.5, 9.0 |
| BXD 6 | 12 | 1.47 ± 0.14 | 17 (32) | 6.0, 7.5, 9.0 |
| BXD 8 | 6 | 1.49 ± 0.14 | 8 (18) | 6.0, 7.5 |
| BXD 9 | 12 | 1.52 ± 0.15 | 13 (33) | 6.0, 7.5, 9.0 |
| BXD 11 | 8 | 1.50 ± 0.12 | 19 (24) | 4.5, 6.0, 7.5, 9.0 |
| BXD 12 | 12 | 1.51 ± 0.07 | 29 (13) | 4.5, 6.0, 7.5, 9.0 |
| BXD 13 | 8 | 1.54 ± 0.13 | 7 (19) | 6.0, 7.5 |
| BXD 14 | 9 | 1.50 ± 0.11 | 15 (37) | 6.0, 7.5, 9.0 |
| BXD 15 | 7 | 1.53 ± 0.16 | 9 (18) | 6.0, 7.5, 9.0 |
| BXD 16 | 9 | 1.49 ± 0.10 | 21 (40) | 6.0, 7.5, 9.0 |
| BXD 18 | 8 | 1.49 ± 0.13 | 20 (30) | 6.0, 7.5, 9.0 |
| BXD 19 | 14 | 1.49 ± 0.10 | 24 (33) | 6.0, 7.5, 9.0 |
| BXD 21 | 13 | 1.50 ± 0.09 | 21 (45) | 6.0, 7.5 |
| BXD 22 | 7 | 1.48 ± 0.09 | 7 (15) | 7.5, 9.0 |
| BXD 23 | 3 | 1.34 ± 0.60 | 3 (5) | 9.0 |
| BXD 24 | 8 | 1.49 ± 0.09 | 13 (20) | 6.0, 7.5, 9.0 |
| BXD 25 | 6 | 1.59 ± 0.34 | 7 (8) | 6.0, 9.0 |
| BXD 27 | 13 | 1.51 ± 0.12 | 22 (30) | 4.5, 6.0, 7.5, 9.0 |
| BXD 28 | 12 | 1.50 ± 0.19 | 7 (15) | 6.0, 9.0 |
| BXD 29 | 12 | 1.49 ± 0.08 | 11 (36) | 7.5, 9.0 |
| BXD 30 | 9 | 1.54 ± 0.12 | 10 (22) | 6.0, 7.5 |
| BXD 31 | 9 | 1.51 ± 0.09 | 14 (29) | 6.0, 7.5, 9.0 |
| BXD 32 | 12 | 1.51 ± 0.09 | 16 (27) | 6.0, 7.5, 9.0 |
Control mice were injected with pyrazole and exposed only to air: data from all mice were used. Mean ± S.E. BEC at time of withdrawal for EtOH-exposed mice was matched to achieve an average of 1.50 mg/ml for each strain.
n = mice used to achieve match (mice used for QTL analyses); N = total mice exposed. Vapor concentrations were those used for mice matched for BEC only. See text for methods.